Trademarkia Logo

Canada

C$
Trademark Search in Canada
BECAUSE ON TIME IS THEIR TIME

View On IC.GC.CA

BECAUSE ON TIME IS THEIR TIME
ADVERTISED

on 9 Apr 2025

Last Applicant/ Owned by

AbbVie AB

Hemvarnsgatan 9Solna, 17154

SE

Serial Number

2060616 filed on 29th Oct 2020

Correspondent Address

BAKER & MCKENZIE LLP

BROOKFIELD PLACE181 BAY STREET, SUITE 2100P.O. BOX 874TORONTO

ONTARIO

CA

M5J2T3

BECAUSE ON TIME IS THEIR TIME

Trademark usage description

pharmaceutical preparations and substances for the treatment of viral, namely, herpes, hepatitis, acquired immune deficiency syndrome (aids), metaboli Read More

Classification Information

Class [005]
Pharmaceutical preparations and substances for the treatment of viral, namely, herpes, hepatitis, acquired immune deficiency syndrome (AIDS), metabolic, namely, diabetes, bulimia nervosa, anorexia, obesity, hypothyroidism, hypoglycemia, gout, osteoarthritis, muscular dystrophy and anemia, endocrine, namely, growth and thyroid disorders, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, namely, urological diseases, infertility, sexually transmitted diseases and inflammatory pelvic diseases, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, namely, Parkinson's, Alzheimer's, Huntington's disease, cerebral palsy, brain injury, spinal cord injury and seizure disorders, gastrointestinal, hormonal, dermatological, namely, psoriasis, dermatitis, skin pigmentation diseases, acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psychiatric, namely, mood disorders, anxiety disorders, cognitive disorders and schizophrenia and immune system, namely, autoimmune diseases and immunologic deficiency syndromes related diseases and disorders

Classification kind code

11

Class [010]
Surgical instruments; medical apparatus for introducing pharmaceutical preparations into the human body; medical apparatus, namely, infusion and injection devices for administering drugs

Classification kind code

11

Class [042]
Science and technology services, namely, providing scientific and technological research in the field of pharmaceuticals and clinical trials; medical and pharmacological research services; provision of information and data relating to medical research; providing scientific information in the field of medical disorders and their treatment; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research; biological research in the field of pharmaceuticals and clinical trials, clinical research in the field of pharmaceuticals and clinical trials and medical research; design and development of computer software for use with medical technology; research on the subject of pharmaceuticals; information technology services for the pharmaceutical and healthcare industries; providing information about the results of clinical trials for pharmaceutical products

Classification kind code

11

Class [044]
Medical assistance, namely, providing a patient assistance and support program for patients and caregivers, namely, providing support, medical advice, and educational information and training on the delivery and administration of medication, conducting clinical trials, medical and scientific research and patient support programs; medical therapy services in the field of pharmaceuticals and clinical trials

Classification kind code

11

Mark Details

Serial Number

2060616

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 42
on 9th Apr 2025		Advertised
Submitted for opposition 27
on 12th Mar 2025		Approval Notice Sent
Submitted for opposition 26
on 12th Mar 2025		Approved
Submitted for opposition 22
on 3rd Sept 2024		Search Recorded
Submitted for opposition 20
on 3rd Sept 2024		Examiner's First Report
Submitted for opposition 287
on 22nd Jun 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 29th Oct 2020		Filed
Submitted for opposition 1
on 29th Oct 2020		Created
Submitted for opposition 31
on 29th Oct 2020		Formalized